BRAND_ANALYSIS #ASTRAZENECA HEALTH & PHARMA #24 OF 26 IN HEALTH & PHARMA ALIGNED

AstraZeneca

· Public · Updated 25 May 2026 11:16 UTC
#1049 of 1208 overall by tension · #24 of 26 in Health & Pharma
7 Aligned
The Aligned Power
Analysis

Big pharma's best-case scenario: C=69, B=76, positive sentiment (0.40) despite sector skepticism. The 1.055 wiki_ratio normalizes what should be opaque; they've made essential-but-unsexy into institutional narrative.

IN THE NEWS (100 articles this week)
AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026 - AstraZeneca
Department of Energy Recognizes AstraZeneca for Achieving SEP 50001 at Gaithersburg Campus in Maryland - Department of Energy (.gov)
FDA approves AstraZeneca’s new kind of hypertension drug - BioPharma Dive
Cultural Score
69 / 100
Business Score
76 / 100
TENSION▁▁▁▁▁▁▁▁▁▁▁▁▁▁
CULTURAL▅▆▅▅▅▅▅▅▅▆▅▆▅▅
BUSINESS▆▅▆▆▆▆▅▅▆▆▅▆▆▆
Loading...
Wikipedia Momentum 29/40
News Presence 40/35
Search InterestRedistributed to other dimensions
Stock Momentum 16/30
Market Position 22/25
Revenue Growth 22/25
Earnings Health 16/20
Avg Daily (7d)582
Avg Daily (90d)552
7d/90d Ratio1.05x
Price$187.03
30d Change-2.7%
Market Cap$290.1B
Profit Margin17.2%
AstraZeneca's tension is 7. Commerce outpacing culture. sociologyofcapitalism.com/brand/astrazeneca
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/astrazeneca.html" width="320" height="200" frameborder="0"></iframe>